Bharat Biotech applies for WHO approval, pre-submission meeting soon
It will have to now go through 3 more stages--pre-submission meeting, dossier accepted for review and the final status of assessment.
💡 newsR Knowledge: Other News Mentions
Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin dosesAfter closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
After suspending Covaxin clinical trials, Brazil closes EUA requestAfter suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programmeBharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
World Health Organisation calls for greater regulation to protect children from 'harmful' e-cigarettesThe head of the World Health Organisation has branded electronic cigarettes "harmful" as he warned their use should be better regulated to protect children and..
WHO Europe Chief Kluge calls for a greater vaccination push
Credit: Euronews English Duration: 07:59Published
China opposes WHO's plan for a second phase of investigation on the origins of Covid | Oneindia News
Credit: Oneindia Duration: 02:00Published
China shuts down city of 9.3 million over 17 COVID cases - as it rejects call for Wuhan lab investigationChina has shut down a city of 9.3 million people over 17 COVID-19 infections, while a proposed second phase of a World Health Organization (WHO) investigation..
You Might Like